Dystrophin-Expressing Chimeric Stem Cell Therapy (Dystrogen Therapeutics)

N/A

Report date: 2025/01/26 18:53:17

Base Information

Drug NameDystrophin-Expressing Chimeric Stem Cell Therapy (Dystrogen Therapeutics)
Drug Alias NameDEC Stem Cell Therapy (Dystrogen Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionDystrophin expression stimulants
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesEurope
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Illinois
China Registration ClassN/A

Develop Information

Active CompaniesDystrogen Therapeutics Corp
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A